CATX Earnings

Quarterly EPS
$-0.21
Q3 2024
$-0.57
Q4 2024
$-0.25
Q1 2025
$-0.29
Q2 2025
$-0.35
Q3 2025
$-0.50
Q4 2025
$-0.25
Q1 2026
$-0.22
Q2 2026
Latest Revenue81.0K
Latest Net Income-26786000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2281.0K-26786000-72.1%+24.1%
Q1 2026-$0.2576.0K-26189000-77.8%+0.0%
Q4 2025-$0.5043.0K-37490000-81.6%+12.3%
Q3 2025-$0.35209.0K-25969000-43.4%-66.7%
Q2 2025-$0.29290.0K-21485000-44.9%-61.1%
Q1 2025-$0.25342.0K-18177000+5.2%+0.0%
Q4 2024-$0.57234.0K-40169000-30.6%
Q3 2024-$0.21369.0K-15122000+33.7%+43.2%
Q2 2024-$0.18526.0K-11704000
Q1 2024-$0.25325.0K-12284000
Q4 2023337.0K-27326000
Q3 2023-$0.37276.0K-10356000
Perspective Therapeutics (CATX) — Earnings